Please provide your email address to receive an email when new articles are posted on . Women with higher BMI, greater anatomical failure and smoking had a greater recurrence of pelvic organ prolapse ...

New research from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Dean Bajorin, MD, and colleagues found that patients who received nivolumab (Opdivo®) after bladder cancer surgery ...

By default, metachronous bladder recurrences after UTUC surgery have been managed similarly to primary non-muscle invasive bladder cancer.

Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle and therefore posed a high ...

By a News Reporter-Staff News Editor at Insurance Daily News-- Current study results on Managed Care have been published. According to news reporting out of San Francisco, California, by NewsRx ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated beneficial responses. Patients with recurrent low-grade intermediate-risk ...

DEAR MAYO CLINIC: I just had a total hysterectomy due to an abnormal Pap smear. At that time, my bladder was also corrected, since it had been descended for many years. What kind of care is most ...

MSK medical oncologist Dean Bajorin says the immunotherapy drug nivolumab proved effective at preventing bladder cancer from returning after surgery. Photo from 2018. Update: On August 19, 2021, the ...

A blood test that can detect tiny amounts of circulating cancer DNA may be able to identify risk of cancer recurrence and guide precision treatment in bladder cancer following surgery, according to a ...